Medical and Pharmaceutical British scientists develop lung cancer blood test that gives results in 40 minutes This new screening device is the product of a 3-year study from Cranfield University scholars Rowan DunneFebruary 7, 2025
Health & Wellness Global lung cancer cases rise at alarming rate among non-smokers, WHO agency finds Pollution appears to be the primary culprit for the phenomenon Rowan DunneFebruary 4, 2025
Alternative Energy Clean energy is critical for reducing lung cancer deaths, expert explains Less fossil fuels, less cases and fatalities, Dr. Joan Schiller says Rowan DunneJanuary 31, 2025
Medical and Pharmaceutical Obesity reduces risk of dying from lung cancer by 21%, South Korean study finds The investigators examined data from more than 7,000 patients over an 11-year period to make this determination Rowan DunneJanuary 30, 2025
AI and Autonomy Light AI develops smartphone tech for diagnosing severe throat infection The Vancouver-based medical equipment company completed its IPO earlier this month Rowan DunneJanuary 29, 2025
Medical and Pharmaceutical FDA gives Zai Lab’s small cell lung cancer therapeutic orphan drug designation About 372,000 people are diagnosed with SCLC annually worldwide Rowan DunneJanuary 27, 2025
Medical and Pharmaceutical Deep learning AI model proves itself useful for CT imaging tumour analysis It was trained by examining over 1,500 CT scans Rowan DunneJanuary 23, 2025
Medical and Pharmaceutical bioAffinity Technologies secures Australian patent for ‘CyPath Lung’ spit test It will be issued within 3 months provided that there are no opposition filings made by third parties Rowan DunneJanuary 22, 2025
Medical and Pharmaceutical University of Waterloo and Princess Margaret Cancer Centre collaborate on innovative cancer research The Canadian Cancer Society reports that healthcare professionals diagnose over 100 types of cancer-related diseases each year Joseph MortonJanuary 21, 2025
Medical and Pharmaceutical Innovent and ASK Pharm scoop Chinese regulator approval for oral lung cancer drug 'Limertinib' targets non-small cell lung cancer with a particular mutation that is prevalent in Asian patients Rowan DunneJanuary 17, 2025